XOMA TECHNOLOGY LTD.
87Patents
62Active
87Granted
51Portfolio score
Filing activity: Jun 6, 1995 → Jul 15, 2021 · 36 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8337851B2 | Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer | Physics | 105 | Active |
| US7867493B2 | PRLR-specific antibody and uses thereof | Physics | 31 | Active |
| US8584349B2 | Flexible manufacturing system | Emerging Cross-Sectional Technologies | 30 | Active |
| US6376211B1 | Agents and methods for inhibiting F1/F0 ATPase | Physics | 25 | Expired |
| US8333970B2 | Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease | Physics | 24 | Active |
| US7531166B2 | IL-1β binding antibodies and fragments thereof | Chemistry; Metallurgy | 23 | Active |
| US6649742B1 | Immunotoxins comprising ribosome-inactivating proteins | Emerging Cross-Sectional Technologies | 21 | Expired |
| US8926976B2 | Modulators | Chemistry; Metallurgy | 20 | Active |
| US7649083B2 | Hepatocyte growth factor (HGF) binding antibody | Chemistry; Metallurgy | 19 | Active |
| US8821879B2 | Anti-botulism antibody coformulations | Emerging Cross-Sectional Technologies | 18 | Active |
| US7582742B2 | Method of treating or preventing an IL-1 related disease or condition | Chemistry; Metallurgy | 17 | Active |
| US7695717B2 | Method of treating an IL-1 related inflammatory disease or condition | Chemistry; Metallurgy | 17 | Active |
| US8569462B2 | Antibodies specific for TGF-beta and methods for treating thereof | Chemistry; Metallurgy | 17 | Active |
| US7094579B2 | Eukaryotic signal sequences for prokaryotic expression | Chemistry; Metallurgy | 16 | Expired |
| US7695718B2 | Methods for the treatment of IL-1β related diseases | Chemistry; Metallurgy | 13 | Active |
| US6582698B1 | Treatment method | Chemistry; Metallurgy | 12 | Expired |
| US7744865B2 | IL1-β Binding antibodies and fragments thereof | Chemistry; Metallurgy | 11 | Active |
| US6461824B1 | Production of chimeric antibodies with specificity to human tumor antigens | Chemistry; Metallurgy | 11 | Expired |
| US6376217B1 | Fusion proteins and polynucleotides encoding gelonin sequences | Chemistry; Metallurgy | 10 | Expired |
| US7829093B2 | Method of treating an IL-1 related autoimmune disease or condition | Chemistry; Metallurgy | 10 | Active |
| US7829094B2 | Method of treating an IL-1 related cancer | Chemistry; Metallurgy | 10 | Active |
| US7744866B2 | IL-1β binding antibodies and binding fragments thereof | Chemistry; Metallurgy | 10 | Active |
| US6455271B1 | Identification of novel antimicrobial agents using membrane potential indicator dyes | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6495516B1 | Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein | Chemistry; Metallurgy | 8 | Expired |
| US6500648B1 | Methods for recombinant peptide production | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.